CN Stock MarketDetailed Quotes

600211 Tibet Rhodiola Pharmaceutical Holding

Watchlist
  • 33.25
  • -0.27-0.81%
Trading Jul 15 13:27 CST
10.72BMarket Cap13.22P/E (TTM)

Tibet Rhodiola Pharmaceutical Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tibet Rhodiola Pharmaceutical Holding Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 27, 2024

Revenue(YoY)

704.22M

-22.35%
EPS(YoY)

1.26

+3.28%
Analyst Rating

Strong Buy

Jul 15, 2024

Tibet Rhodiola Pharmaceutical Holding Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
--------

Unlock Free Earnings Estimates

Tibet Rhodiola Pharmaceutical Holding Earnings Reports

  • Tibet Pharmaceutical Report for the First Quarter of 2024

    Apr 26 12:00 ET

  • Summary of Tibet Pharmaceutical's 2023 Annual Report

    Mar 26 12:00 ET

  • Tibet Pharmaceutical 2023 Annual Report

    Mar 26 12:00 ET

  • Tibet Nordicang Pharmaceutical Co., Ltd. 2023 Annual Results Advance Notice

    Jan 18 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 15, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg